Enanta Pharmaceuticals (ENTA)
(Delayed Data from NSDQ)
$10.47 USD
-0.20 (-1.87%)
Updated Sep 26, 2024 04:00 PM ET
After-Market: $10.48 +0.01 (0.10%) 7:06 PM ET
3-Hold of 5 3
C Value D Growth A Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/18/2024
Time: -- |
9/2024 | $-1.16 | 0.00% |
Earnings Summary
For their last quarter, Enanta Pharmaceuticals (ENTA) reported earnings of -$1.07 per share, beating the Zacks Consensus Estimate of $-1.49 per share. This reflects a positive earnings surprise of 28.19%. Look out for ENTA's next earnings release expected on November 18, 2024. For the next earning release, we expect the company to report earnings of -$1.16 per share, reflecting a year-over-year increase of 12.78%.
Earnings History
Price & Consensus
Zacks News for ENTA
Enanta Pharmaceuticals (ENTA) Soars 6.7%: Is Further Upside Left in the Stock?
ENTA: What are Zacks experts saying now?
Zacks Private Portfolio Services